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Abstract  
BACKGROUND: Primary fallopian tube carcinoma (PFTC) is a rare tumour of the female genital tract with an 
incidence of 0.1-1.8% of all genital malignancies, and it is very difficult to diagnose preoperatively, because of its 
non-specific symptomatology. In most cases, it is an intraoperative finding or a histopathological diagnosis. It is a 
tumour that histologically and clinically resembles epithelial ovarian cancer. 
 
CASE PRESENTATION: We are reporting a case of a 62-year-old, postmenopausal women with primary 
fallopian tube carcinoma of the right fallopian tube in stage IA. The patient has lower abdominal pain, watery 
vaginal discharge and repeated episodes of bleeding from the vagina. The clinical and radiological findings 
suggested a right adnexal tumour with elevated CA-125 levels. Total abdominal hysterectomy, bilateral salpingo-
oophorectomy, omentectomy and peritoneal washing were performed. Pathologic confirmation of primary serous 
cystadenocarcinoma of the right fallopian tube was made. Peritoneal washings were negative for malignancy. 
FIGO stage was considered as IA, and the patient received no courses of chemotherapy and postoperative 
radiation because she refused it. Ten months after initial surgery, the patient is alive and in good condition. 
CONCLUSION: Cytoreduction surgery followed by adequate cycles of chemotherapy is an important strategy to 
improve patients’ prognosis. 
 
 
 
 
 
 
 
 
Introduction 
 
Primary fallopian tube carcinoma (PFTC) is a 
very rare gynecologic malignant tumor and accounts 
for approximately 0.14-1.8% of female genital 
malignancies [1-7]. In 1847, Renaud first described 
fallopian tube malignancy. In 1888, Orthmann 
presented the first genuine case report [7]. Since then 
over 2000 case have been reported in literature.  
Its incidence has been rising during the last 
decades and varied between 2.9/1,000,000 and 
5.7/1,000,000 [8]. Histologic, molecular and genetic 
evidence shows that from 40-60% of tumours that 
were classified as high-grade serous carcinomas of 
the ovary or peritoneum may have originated in the 
fimbrial and of the fallopian tube. Therefore the 
incidence of fallopian tube cancers may have been 
underestimated [9]. The aetiology of this tumour is 
unknown enough; it is suggested to be associated 
with chronic tubal inflammation, infertility, tuberculous 
salpingitis and tubal endometriosis [10]. Similar to 
ovarian malignancy, a BRCA germline mutation and 
TP53 mutation are associated with fallopian tube 
malignancy [11, 12].
 
Clinical symptoms and sings are non-specific 
and include lower abdominal, pelvic pain, 
serosanguinous vaginal discharge and pelvic mass 
[13, 14]. The rate of preoperative diagnosis was in the 
range of 0%-10% [15] and most cases it is an 
intraoperative finding or a histopathological diagnosis 
[16]. We are reporting a rare case of fallopian tube 
carcinoma in a 62-year-old female, with a review of 
the literature.
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Case Report 
 
We present a 62-year-old, post menopausal 
women who was gravid 4, para 2, living child 2 (Parity 
Index –G4P2L2), married, with no significant personal 
or family history. Her two deliveries were spontaneous 
vaginal deliveries, and she had been post-
menopausal since past 16 years. She presented with 
the complaints of severe lower abdominal pain and 
intermittent vaginal bleeding and discharge that had 
occurred for the previous six months. The abdominal 
pain was a dull ache in the right lower abdomen which 
propagated to the back. The vaginal discharge was 
watery in consistency. For her medical history, she 
had taken antihypertension medication for the past 
eight years. On the admission day, her blood pressure 
was 140/90 mmHg, the puls rate was 80 beats per 
minute, and her temperature was 37.5
0
C. She had 
already tried conservative treatment, which had not 
improved her symptoms. Her hemogram, hepatic and 
renal functions were normal. Blood sugar and urine 
examination were normal. 
On the physical examination was noticed left 
lateral lower quadrant tenderness. The pelvic 
examination revealed a normal sized anteverted 
uterus with cervical motion and adnexal tenderness. 
Speculum examination showed minimal bleeding with 
a healthy cervix and vagina. 
Transabdominal sonography showed uterus 
with normal echostructure, measuring 64x52x38 mm. 
Endometrial thickness was 5 mm. Left ovary 
measured 20 x 15 x 10 mm and had normal 
echostructure. Unilateral heterogenous longitudinal 
mass, multilocular cyst with incomplete septation 
showed in the right adnexa, and the mass measured 
7.2 x 4.6, which suggested right tube-ovarian 
abscess. 
 
 
Figure 1: Transabdominal ultrasonography showing a multilocular 
cyst with incomplete septation  
 
Free fluid was not seen in the abdomen. 
Computerised tomography (CT) was not done. The 
white cell count on admission was 18.4 x 10
9
/L, and 
the C-reactive protein level was 14.26 mg/dl. The Ca 
125 antigen level was 162.20 U/ml (normal up to 35 
U/ml), the Ca 19-9 and CEA levels was normal. Based 
on the clinical pictures and laboratory results a right 
tube-ovarian abscess was suspected, and broad 
spectrum parenteral antibiotics were established. The 
Pap smear was within normal limits. 
 
A diagnostic curettage was performed which 
showed atrophic endometrium. In exploratory 
laparotomy was found hydrosalpinx on the right side 
with severe adhesions between the right adnexa, 
intestine and uterus. The patient underwent total 
abdominal hysterectomy, bilateral salpingo-
oophorectomy, partial omentectomy with adhesiolysis 
and peritoneal washing was performed.The bilateral 
ovarian masses, fallopian tubes, uterus, omentum and 
sample of peritoneal washing were sent for 
histopathological analysis. The histopathologic 
examination showed primary serous cyst 
adenocarcinoma of the right fallopian tube with no 
serosa invasion. The tuba was tortuous, 17 cm in 
length with 5 cm long dilatation in the proximal third. In 
the dilated part, few exophytic, neoplastic, white-
grayish soft lesions were found. 
 
 
 
Figure 2: Tortuous fallopian tube (up), exophytic, neoplastic white 
grayish soft lesions (down)
 
 
The histopathologic examination revealed 
areas of in situ as well as high-grade primary serous 
adenocarcinoma of the fallopian tube with lamina 
propria involvement.  
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a)  
b)  
c)  
Figure 3: a) HE x 4 Adenocarcinoma tube; b) HE x 10 intact 
musculature; c) HE x 40 malignant epithelium
 
 
The malignant cells were positive for CK7, 
WT1 and P53, the tumour did not infiltrate the muscle 
layer, so it was defined as FIGO stage IA (pTNM = 
pT1A pNx pMx stage IA).  
The uterus, ovaries, left the fallopian tube and 
the peritoneal washing fluid was free of tumour. In our 
case the pre-operative diagnosis was incorrect. This is 
the fact that Fallopian tube carcinomas are almost 
difficult to diagnose preoperatively due to the rarity 
and silent course of this neoplasm. The patient was 
discharged, seven days after the surgery and was 
referred to an oncologist for chemotherapy.
 
 
 
Discussion 
 
Primary Fallopian tube carcinoma is the rarest 
malignancy of the female genital tract and was first 
described by Renand in 1897 [17]. Rokitansky 
recorded the first microscopic description in 1861 and 
Orthman presented a first case report in 1888 [18]. 
Clinically and histologically (PFTC) resemble epithelial 
ovarian cancer (EOC), and it is difficult to distinguish 
from serious epithelial ovarian cancer or primary 
peritoneal serous carcinoma during or after operation 
[19]. 
 
a)  
b)  
c)  
Figure 4: a) CK7 x 10 immunostaining positive with CK7 antibody; 
b) WT1 x 20  immunostaining positive with WT1 antibody; c) P53 x 
20  immunostaining positive with P53 antibody 
 
EOC is often diagnosed at an advanced 
stage, but PFTC is found more in an early stage, 
because of abdominal pain from tubal distension and 
a shorter history of symptoms in PFTC than in EOC 
[20]. The aetiology of this cancer is unknown. High 
parity has been reported to be protective, and use of 
oral contraceptives and pregnancy decreases the risk 
of PFTC [8]. Most patients with PFTC are 
postmenopausal. The peak incidence is between the 
ages 60 and 64 years, with the mean age of incidence 
being 55 years (age range 17-88 years) [21].  
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Our patient was postmenopausal. She doesn't 
have a predisposing factor. Pelvic inflammatory 
disease, nulliparity and subfertility were not present in 
our case.
 
The clinical symptoms and signs of PFTC are 
not specific. The most common symptoms and signs 
are abdominal pain, which may be colicky as a result 
of forced tubal peristalsis or dull as a result of tubal 
distension and vaginal bleeding or watery discharge 
[22]. The Latzko’s triad of typical symptoms consists 
of intermittent profuse serosanguinous vaginal 
bleeding, colicky pain relieved by discharge and an 
abdominal or pelvic mass. This triad was reported in 
only 15% of PFTC cases [14]. 
In our case, all of these symptoms were 
presented. In most cases, the preoperative diagnosis 
of PFTC is extremely rare [23]. The rate of 
preoperative diagnosis was in the range of 0%-10% 
[24], and up to 50% are missed intraoperatively [25]. 

 
PFTC should be included in the differential 
diagnosis and if the patient has clinical symptoms 
such as vaginal discharge or abnormal genital 
bleeding or spotting with negative diagnostic 
curettage. Pap smear positivity occurs in 10%-36% of 
cases [14, 26].  
In our patient diagnostic curettage and Pap 
smear were negative. The CA-125 level is raised. Ca-
125 is a useful tumour marker for the diagnosis, 
assessment of response to treatment and detection of 
tumour recurrence during follow-up. 80% of patients 
with PFTC have elevated pretreatment serum levels 
of CA 125 [27].
 
The diagnostic criteria for PFTC were first 
established by Hu and colleagues and later slightly 
modified by Sidles. Accordingly, PFTC is diagnosed if: 
grossly, the main tumor is in the tube and arises from 
the endo salpinx; the histological pattern reproduces 
the epithelium of tubal mucosa; transition from benign 
to malignant tubal epithelium should be demonstrated, 
and ovaries and endometrium are either normal or 
have a much smaller tumor volume than that of the 
tube [28, 29].
 
Approximately 90% of ovarian cancers are 
carcinomas (malignant epithelial tumors) and based 
on histopathology, immunohistochemistry and 
molecular genetic analyzes, at least 5 main types are 
currently distinguished: high-grade serous carcinoma 
(HGSC, 70%); endometrioid carcinoma (EC, 10%); 
clear-cell carcinoma (CCC, 10%); mucinous 
carcinoma (MC, 3%); and low-grade serous 
carcinoma (LGSC, <5%) [30].
 
Imaging for suspected gynecologic 
malignancies includes ultrasound, computed 
tomography (CT) scan and magnetic resonance 
imaging (MRI) of the abdomen. Transvaginal and 
transabdominal ultrasound is the simplest and usually 
initial imaging investigation. Although the ultrasound 
findings of tubal carcinoma are nonspecific and mimic 
other pelvic diseases such as an ovarian tumour or 
tube-ovarian abscess, several findings may provide a 
diagnostic clue preoperatively. The echogram may 
show a cystic mass with spaces and mural nodules, a 
sausage-shaped mass or a multilobular mass with a 
cog-and-wheel appearance [31, 32].  
The lesion can have the appearance of a 
small, solid, lobulated mass on CT scan or MRI. On 
CT scan, a solid papillary intratubal mass allows for 
easy prediction of PFTC. MRI is considered a better 
method than CT or ultrasound for detecting tumour 
infiltration of extramural organs [33].
 
Surgery is the treatment of choice for PFTC 
and is similar to that for ovarian carcinoma-
cytoreductive surgery with the removal of the tumour 
as much as possible. The procedure of choice is total 
abdominal hysterectomy, bilateral salpingo-
oophorectomy, omentectomy, selective pelvic and 
para-aortic lymphadenectomy for any stage of 
fallopian tube carcinoma [9, 13]. Postoperative 
platinum- based combination adjuvant chemotherapy 
is the most commonly used therapy for these patients, 
similar to EOC patients. The role of postoperative 
radiotherapy is even less clear [4, 9].  
The reported overall responses rates are 53-
92%.The stage of disease at the time of diagnosis is 
the most important factor affecting the prognosis [6]. 
The other prognostic factors include the residual 
volume of the tumour after cytoreduction, the 
presence of ascites and the histologic grade of the 
tumour [6, 9].  
In conclusion, primary fallopian tube 
carcinoma is a rare gynecologic malignancy that 
accounts for less than 1% of all malignancies of the 
female genitalia. Preoperative diagnosis of fallopian 
tube carcinoma is difficult due to the silent course of 
this neoplasm and is usually first appreciated at the 
time of operation or by a pathologist. PFTC 
histologically and clinically resembles epithelial 
ovarian carcinoma. The symptom complex of "hydrops 
tube pro fluence" said to be pathognomonic for this 
tumour, is rarely encountered. It should be considered 
in differential diagnosis of peri and postmenopausal 
women who present with unexplained uterine 
bleeding, pelvic pain, adnexal mass, abnormal 
cervical smear and complicated pelvic inflammatory 
disease. The treatment approach is similar to that of 
ovarian carcinoma, and it should consist of a total 
abdominal hysterectomy with bilateral salpingo-
ovariectomy, omentectomy and lymph node dissection 
from the pelvic and the para-aortic regions. 
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